糖尿病对BEST-CLI试验中慢性肢体威胁性缺血血运重建结局的影响
基于BEST-CLI试验1777例接受下肢血运重建的患者,69.2%合并糖尿病。糖尿病患者3年MALE或全因死亡估计为53.5% vs 无糖尿病者46.4%(P < .001),校正后糖尿病独立关联膝上截肢(1.75 [1.22-2.51])、全因死亡(1.63 [1.31-2.03])及MALE或全因死亡(1.24 [1.04-1.47])。
要点
- BEST-CLI试验中接受下肢血运重建者69.2%合并糖尿病。
- 糖尿病患者更多表现为晚期WIfI分期3-4(73.7% vs 45.9%;P < .001)。
- 校正后糖尿病独立关联膝上截肢、全因死亡及MALE或全因死亡。
核心结论
- 因慢性肢体威胁性缺血接受下肢血运重建的糖尿病患者,MALE或全因死亡发生率高于无糖尿病者。
- 糖尿病的影响似乎由就诊时更严重的伤口和感染以及更高的心脏和肾脏疾病患病率所介导。
研究设计与样本
- BEST-CLI试验中比较合并与不合并糖尿病的患者,共1777例接受下肢血运重建。
- 采用Cox回归分析糖尿病与MALE、再干预、膝上截肢及全因死亡的关联。
主要发现
- 糖尿病患者显著更年轻、白人比例更低、西班牙裔比例更高。
- 糖尿病患者高血压、高脂血症、冠心病、充血性心力衰竭和肾脏疾病比例更高,且接受最佳药物治疗(抗血小板和的他汀)比例更高;无糖尿病者吸烟和慢性阻塞性肺疾病比例显著更高。
- 糖尿病患者WIfI分期3-4比例显著更高(73.7% vs 45.9%;P < .001),主要由伤口和感染分级差异驱动。
- 无糖尿病者踝压和趾压显著更低,WIfI缺血3级比例显著更高(60% vs 52.5%;P = .016)。
- 3年时糖尿病患者膝上截肢和全因死亡发生率更高;Kaplan-Meier分析显示MALE或全因死亡显著更高(3年估计:53.5% vs 46.4%;P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Several observational studies have demonstrated an association between diabetes mellitus (DM) and above-ankle amputation after lower extremity revascularization (LER). However, data from prospective randomized trials is lacking. This analysis compares the outcomes of patients with and without DM enrolled in the Best Endovascular vs Best Surgical Therapy in patients with Chronic Limb-Threatening Ischemia (BEST-CLI) trial. METHODS: Baseline characteristics were compared between patients with and without DM in the BEST-CLI trial. Cox regression was used to determine the association between DM and major outcomes of major adverse limb events (MALE), reintervention, above-ankle amputation, and all-cause death. RESULTS: Among 1777 patients who underwent LER, 69.2% had DM. Compared with patients without DM, those with DM were significantly younger, less likely to be White, and more likely to be Hispanic. Patients with DM were more likely to have hypertension, hyperlipidemia, coronary artery disease, congestive heart failure, and renal disease and be on optimal medical therapy (antiplatelets and statins), whereas patients without DM were significantly more likely to be smokers and have chronic obstructive pulmonary disease. Patients with DM were significantly more likely to present with late Wound Ischemia foot Infection (WIfI) stages (3-4) (73.7% vs 45.9%; P < .001) that were driven predominantly by differences in wound and infection grade. Conversely, patients without DM had significantly lower ankle pressures and toe pressures and were significantly more likely to have WIfI ischemia grade 3 compared with patients with DM (60% vs 52.5%; P = .016). At 3 years, patients with DM exhibited higher rates of above-ankle amputation and all-cause death compared with patients without DM. Kaplan-Meier analysis demonstrated significantly higher MALE or all-cause death compared with patients without DM (3-year estimate: 53.5% vs 46.4%; P < .001). After adjusting for potential confounders, regression analysis demonstrated that DM was independently associated with increased above-ankle amputation (1.75 [1.22-2.51]), all-cause death (1.63 [1.31-2.03]), and MALE or all-cause death (1.24 [1.04-1.47]). CONCLUSIONS: Patients with DM undergoing LER for chronic limb-threatening ischemia experienced a greater incidence of MALE or all-cause death compared with patients without DM. The impact of DM seems to be mediated by more severe wounds and infections at the time of presentation, and a higher prevalence of cardiac and renal disease.
引用
- Ochoa Chaar CI, Malas M, Doros G, et al. The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024. PMID: 39332785. doi:10.1016/j.jvs.2024.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。